Adherent-invasive Escherichia coli induce claudin-2 expression and barrier defect in CEABAC10 mice and Crohn's disease patients

Inflammatory Bowel Diseases

Volumn 18, Issue 2, 2012, Pages 294-304

  Denizot, Jeremy ^a   Sivignon, Adeline ^a,b   Barreau, Frederick ^c   Darcha, Claude ^d   Chan, H F Carlos ^e,f   Stanners, Clifford P ^f,g   Hofman, Paul ^f   Darfeuille Michaud, Arlette ^a,b   Barnich, Nicolas ^a,b  

^a UNIVERSITÉ CLERMONT AUVERGNE   (France)

^b CEMAGREF   (France)

^c Institut Universitaire de Technologie   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f MCGILL UNIVERSITY   (Canada)

^g MCGILL UNIVERSITY   (Canada)

Author keywords

barrier function; CEACAMs molecules; claudin 2; inflammatory bowel disease; type 1 pili

Indexed keywords

BIOTIN; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CLAUDIN 2; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; PILIN;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; CROHN DISEASE; ESCHERICHIA COLI; FEMALE; HUMAN; HUMAN TISSUE; ILEUM; IMMUNOHISTOCHEMISTRY; INTESTINE BIOPSY; INTESTINE EPITHELIUM CELL; INTESTINE MUCOSA; INTESTINE MUCOSA PERMEABILITY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TISSUE MICROARRAY; TRANSGENIC MOUSE;

ADULT; ANIMALS; ANTIGENS, CD; BACTERIAL ADHESION; CELL ADHESION MOLECULES; CLAUDINS; CROHN DISEASE; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FEMALE; GPI-LINKED PROTEINS; HUMANS; ILEUM; INTESTINES; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; PERMEABILITY; TISSUE ARRAY ANALYSIS;

EID: 84855644351     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21787     Document Type: Article

References (50)

1. Podolsky DK,. Inflammatory bowel disease. N Engl J Med. 2002; 347: 417-429. (Pubitemid 34851835)
2. Strober W, Fuss I, Mannon P,. The fundamental basis of inflammatory bowel disease. J Clin Invest. 2007; 117: 514-521. (Pubitemid 46348505)
3. Darfeuille-Michaud A, Boudeau J, Bulois P, et al. High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology. 2004; 127: 412-421. (Pubitemid 39091889)
4. Barnich N, Darfeuille-Michaud A,. Role of bacteria in the etiopathogenesis of inflammatory bowel disease. World J Gastroenterol. 2007; 13: 5571-5576. (Pubitemid 350031476)
5. Carvalho FA, Barnich N, Sivignon A, et al. Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM. J Exp Med. 2009; 206: 2179-2189.
6. Wine E, Ossa JC, Gray-Owen SD, et al. Adherent-invasive Escherichia coli, strain LF82 disrupts apical junctional complexes in polarized epithelia. BMC Microbiol. 2009; 9: 180.
7. Sasaki M, Sitaraman SV, Babbin BA, et al. Invasive Escherichia coli are a feature of Crohn's disease. Lab Invest. 2007; 87: 1042-1054. (Pubitemid 47429187)
8. Gitter AH, Wullstein F, Fromm M, et al. Epithelial barrier defects in ulcerative colitis: characterization and quantification by electrophysiological imaging. Gastroenterology. 2001; 121: 1320-1328. (Pubitemid 33140449)
9. Benjamin J, Makharia GK, Ahuja V, et al. Intestinal permeability and its association with the patient and disease characteristics in Crohn's disease. World J Gastroenterol. 2008; 14: 1399-1405. (Pubitemid 351425221)
10. Vogelsang H,. Do changes in intestinal permeability predict disease relapse in Crohn's disease? Inflamm Bowel Dis. 2008; 14 (suppl 2): S162-163.
11. Ambrose NS, Johnson M, Burdon DW, et al. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg. 1984; 71: 623-625. (Pubitemid 14098950)
12. Takesue Y, Ohge H, Uemura K, et al. Bacterial translocation in patients with Crohn's disease undergoing surgery. Dis Colon Rectum. 2002; 45: 1665-1671. (Pubitemid 35471019)
13. Bruewer M, Samarin S, Nusrat A,. Inflammatory bowel disease and the apical junctional complex. Ann N Y Acad Sci. 2006; 1072: 242-252. (Pubitemid 44448457)
14. Wyatt J, Vogelsang H, Hubl W, et al. Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet. 1993; 341: 1437-1439. (Pubitemid 23161445)
15. Zeissig S, Burgel N, Gunzel D, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease. Gut. 2007; 56: 61-72. (Pubitemid 46044890)
16. Darfeuille-Michaud A, Neut C, Barnich N, et al. Presence of adherent Escherichia coli strains in ileal mucosa of patients with Crohn's disease. Gastroenterology. 1998; 115: 1405-1413. (Pubitemid 28545991)
17. Chan CH, Stanners CP,. Novel mouse model for carcinoembryonic antigen-based therapy. Mol Ther. 2004; 9: 775-785. (Pubitemid 38878124)
18. Cesaro A, Abakar-Mahamat A, Brest P, et al. Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia. Am J Physiol Gastrointest Liver Physiol. 2009; 296: G1332-1343.
19. Cesaro A, Brest P, Hofman V, et al. Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration. Am J Physiol Gastrointest Liver. Physiol. 2010; 299: G32-42.
20. Rolhion N, Barnich N, Bringer MA, et al. Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion. Gut. 2010; 59: 1355-1362.
21. Stecher B, Robbiani R, Walker AW, et al. Salmonella enterica serovar typhimurium exploits inflammation to compete with the intestinal microbiota. PLoS Biol. 2007; 5: 2177-2189. (Pubitemid 350035420)
22. Wadolkowski EA, Laux DC, Cohen PS,. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of growth in mucus. Infect Immun. 1988; 56: 1030-1035.
23. Hogardt M, Trebesius K, Geiger AM, et al. Specific and rapid detection by fluorescent in situ hybridization of bacteria in clinical samples obtained from cystic fibrosis patients. J Clin Microbiol. 2000; 38: 818-825. (Pubitemid 30082687)
24. Barnich N, Carvalho FA, Glasser AL, et al. CEACAM6 acts as a receptor for adherent-invasive E. coli, supporting ileal mucosa colonization in Crohn disease. J Clin Invest. 2007; 117: 1566-1574. (Pubitemid 46871341)
25. Laukoetter MG, Bruewer M, Nusrat A,. Regulation of the intestinal epithelial barrier by the apical junctional complex. Curr Opin Gastroenterol. 2006; 22: 85-89. (Pubitemid 44090070)
26. Laukoetter MG, Nava P, Nusrat A,. Role of the intestinal barrier in inflammatory bowel disease. World J Gastroenterol. 2008; 14: 401-407. (Pubitemid 351320848)
27. Mankertz J, Schulzke JD,. Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications. Curr Opin Gastroenterol. 2007; 23: 379-383. (Pubitemid 46878948)
28. Schulzke JD, Bojarski C, Zeissig S, et al. Disrupted barrier function through epithelial cell apoptosis. Ann N Y Acad Sci. 2006; 1072: 288-299. (Pubitemid 44448461)
29. Schulzke JD, Ploeger S, Amasheh M, et al. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci. 2009; 1165: 294-300.
30. Vetrano S, Rescigno M, Cera MR, et al. Unique role of junctional adhesion molecule-a in maintaining mucosal homeostasis in inflammatory bowel disease. Gastroenterology. 2008; 135: 173-184. (Pubitemid 351899025)
31. Weber CR, Turner JR,. Inflammatory bowel disease: is it really just another break in the wall? Gut. 2007; 56: 6-8. (Pubitemid 46044880)
32. Chan CH, Camacho-Leal P, Stanners CP,. Colorectal hyperplasia and dysplasia due to human carcinoembryonic antigen (CEA) family member expression in transgenic mice. PLoS One. 2007; 2: e1353.
33. Benchimol S, Fuks A, Jothy S, et al. Carcinoembryonic antigen, a human tumor marker, functions as an intercellular adhesion molecule. Cell. 1989; 57: 327-334. (Pubitemid 19112371)
34. Olson TS, Reuter BK, Scott KG, et al. The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med. 2006; 203: 541-552.
35. Swidsinski A, Ladhoff A, Pernthaler A, et al. Mucosal flora in inflammatory bowel disease. Gastroenterology. 2002; 122: 44-54. (Pubitemid 34049193)
36. Baumgart M, Dogan B, Rishniw M, et al. Culture independent analysis of ileal mucosa reveals a selective increase in invasive Escherichia coli of novel phylogeny relative to depletion of Clostridiales in Crohn's disease involving the ileum. Isme J. 2007; 1: 403-418. (Pubitemid 47373247)
37. Eaves-Pyles T, Allen CA, Taormina J, et al. Escherichia coli isolated from a Crohn's disease patient adheres, invades, and induces inflammatory responses in polarized intestinal epithelial cells. Int J Med Microbiol. 2008; 298: 397-409. (Pubitemid 351734791)
38. Martinez-Medina M, Aldeguer X, Lopez-Siles M, et al. Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease. Inflamm Bowel Dis. 2009; 15: 872-882.
39. Katz KD, Hollander D, Vadheim CM, et al. Intestinal permeability in patients with Crohn's disease and their healthy relatives. Gastroenterology. 1989; 97: 927-931. (Pubitemid 19239031)
40. Teahon K, Smethurst P, Levi AJ, et al. Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut. 1992; 33: 320-323.
41. Prasad S, Mingrino R, Kaukinen K, et al. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest. 2005; 85: 1139-1162. (Pubitemid 43073987)
42. Furuse M, Furuse K, Sasaki H, et al. Conversion of zonulae occludentes from tight to leaky strand type by introducing claudin-2 into Madin-Darby canine kidney I cells. J Cell Biol. 2001; 153: 263-272. (Pubitemid 34280213)
43. Roxas JL, Koutsouris A, Bellmeyer A, et al. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest. 2010; 90: 1152-1168.
44. Reuter BK, Pizarro TT,. Mechanisms of tight junction dysregulation in the SAMP1/YitFc model of Crohn's disease-like ileitis. Ann N Y Acad Sci. 2009; 1165: 301-307.
45. Arnott ID, Kingstone K, Ghosh S,. Abnormal intestinal permeability predicts relapse in inactive Crohn disease. Scand J Gastroenterol. 2000; 35: 1163-1169.
46. D'Inca R, Di Leo V, Corrao G, et al. Intestinal permeability test as a predictor of clinical course in Crohn's disease. Am J Gastroenterol. 1999; 94: 2956-2960. (Pubitemid 29482764)
47. Hilsden RJ, Meddings JB, Hardin J, et al. Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis. 1999; 5: 85-91.
48. Jorgensen J, Ranlov PJ, Bjerrum PJ, et al. Is an increased intestinal permeability a valid predictor of relapse in Crohn disease? Scand J Gastroenterol. 2001; 36: 521-527. (Pubitemid 32328443)
49. Tibble JA, Sigthorsson G, Bridger S, et al. Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology. 2000; 119: 15-22. (Pubitemid 30452574)
50. Wild GE, Waschke KA, Bitton A, et al. The mechanisms of prednisone inhibition of inflammation in Crohn's disease involve changes in intestinal permeability, mucosal TNFalpha production and nuclear factor kappa B expression. Aliment Pharmacol Ther. 2003; 18: 309-317. (Pubitemid 37046710)